Ganoderma lucidum: A rational pharmacological approach to surmount cancer

MF Ahmad - Journal of ethnopharmacology, 2020 - Elsevier
Ethnopharmacological relevance Ganoderma lucidum (G. lucidum) has been broadly used
for health endorsement as well as longevity for over 2000 years in Asian countries. It is an …

Genetic polymorphisms and esophageal cancer risk

T Hiyama, M Yoshihara, S Tanaka… - International journal of …, 2007 - Wiley Online Library
The aim of this paper is to review and evaluate, in a comprehensive manner, the published
data regarding the contribution of genetic polymorphisms to risk of esophageal cancer …

Ganoderma: insights into anticancer effects

NV Kladar, NS Gavarić, BN Božin - European Journal of Cancer …, 2016 - journals.lww.com
The genus Ganoderma includes about 80 species growing on cut or rotten trees. The most
commonly used species is Ganoderma ludicum. Biomolecules responsible for the health …

Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China

Z Wang, L Tang, G Sun, Y Tang, Y Xie, S Wang, X Hu… - BMC cancer, 2006 - Springer
Background Continuous exposure to various environmental carcinogens and genetic
polymorphisms of xenobiotic-metabolizing enzymes (XME) are associated with many types …

Mechanisms of the Anticancer Action of Ganoderma lucidum (Leyss. ex Fr.) Karst.: A New Understanding

GQ LIU, KC ZHANG - Journal of Integrative Plant Biology, 2005 - Wiley Online Library
Ganoderma lucidum (Leyss. ex Fr.) Karst., a medicinal fungus called “Lingzhi” in China, has
been used in traditional Chinese medicine in China for the prevention and treatment of …

Exploring SNP‐SNP interactions and colon cancer risk using polymorphism interaction analysis

JE Goodman, LE Mechanic, BT Luke… - … journal of cancer, 2006 - Wiley Online Library
Several single nucleotide polymorphisms (SNPs) in genes derived from distinct pathways
are associated with colon cancer risk; however, few studies have examined SNP‐SNP …

Genetic variations in esophageal cancer risk and prognosis

WY Cheung, G Liu - Gastroenterology Clinics of North America, 2009 - Elsevier
Investigations into inherited genetic variations in the DNA code (known as polymorphisms)
in the field of oncology have provided preliminary support for an association with cancer …

[HTML][HTML] Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature

CX Yang, K Matsuo, ZM Wang… - World Journal of …, 2005 - ncbi.nlm.nih.gov
AIM: Phase I/II enzymes metabolize environmental carcin-ogens and several functional
polymorphisms have been reported in their encoding genes. Although their significance with …

Genetic predisposition to gastro-oesophageal cancer

P Lao-Sirieix, C Caldas, RC Fitzgerald - Current opinion in genetics & …, 2010 - Elsevier
Gastro-oesophageal cancers were ranked as the second cause of death from cancer
worldwide despite a steady decrease in incidence for squamous cell carcinoma (SCC) of the …

GSTM1 and GSTT1 polymorphism and susceptibility to esophageal cancer in high- and low-risk regions of India

A Sharma, BC Das, A Sehgal, R Mehrotra, P Kar… - Tumor Biology, 2013 - Springer
Glutathione transferases, a super family of dimeric phase II metabolic enzymes play a vital
role in biotransformation of many substances. This study evaluates the influence of genetic …